Literature DB >> 26321271

Mitochondrial mechanisms of endothelial dysfunction.

Adam Szewczyk1, Wieslawa Jarmuszkiewicz2, Agnieszka Koziel2, Izabela Sobieraj2, Wioletta Nobik2, Agnieszka Lukasiak3, Agata Skup1, Piotr Bednarczyk3, Beata Drabarek4, Dorota Dymkowska4, Antoni Wrzosek5, Krzysztof Zablocki4.   

Abstract

Endothelial cells play an important physiological role in vascular homeostasis. They are also the first barrier that separates blood from deeper layers of blood vessels and extravascular tissues. Thus, they are exposed to various physiological blood components as well as challenged by pathological stimuli, which may exert harmful effects on the vascular system by stimulation of excessive generation of reactive oxygen species (ROS). The major sources of ROS are NADPH oxidase and mitochondrial respiratory chain complexes. Modulation of mitochondrial energy metabolism in endothelial cells is thought to be a promising target for therapy in various cardiovascular diseases. Uncoupling protein 2 (UCP2) is a regulator of mitochondrial ROS generation and can antagonise oxidative stress-induced endothelial dysfunction. Several studies have revealed the important role of UCP2 in hyperglycaemia-induced modifications of mitochondrial function in endothelial cells. Additionally, potassium fluxes through the inner mitochondrial membrane, which are involved in ROS synthesis, affect the mitochondrial volume and change both the mitochondrial membrane potential and the transport of calcium into the mitochondria. In this review, we concentrate on the mitochondrial role in the cytoprotection phenomena of endothelial cells.
Copyright © 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Endothelial dysfunction; Mitochondria; Mitochondrial potassium channels; Reactive oxygen species; Uncoupling protein

Mesh:

Substances:

Year:  2015        PMID: 26321271     DOI: 10.1016/j.pharep.2015.04.009

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  30 in total

1.  Cardiometabolic risk factors are associated with immune cell mitochondrial respiration in humans.

Authors:  Theodore M DeConne; Eric R Muñoz; Faria Sanjana; Joshua C Hobson; Christopher R Martens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-17       Impact factor: 4.733

2.  Preconditioning with the BKCa channel activator NS-1619 prevents ischemia-reperfusion-induced inflammation and mucosal barrier dysfunction: roles for ROS and heme oxygenase-1.

Authors:  Hongyan Dai; Meifang Wang; Parag N Patel; Theodore Kalogeris; Yajun Liu; William Durante; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

3.  Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta.

Authors:  Brandi M Wynne; Hicham Labazi; Zidonia N Carneiro; Rita C Tostes; R Clinton Webb
Journal:  Eur J Pharmacol       Date:  2017-08-20       Impact factor: 4.432

4.  Evidence of microvascular dysfunction in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Jeffrey Thomas; Nichole Seigler; Reva Crandall; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-15       Impact factor: 4.733

5.  Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease.

Authors:  Danielle L Kirkman; Bryce J Muth; Meghan G Ramick; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08

6.  Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage-related diseases.

Authors:  Jianbin Bi; Jia Zhang; Yifan Ren; Zhaoqing Du; Yuanyuan Zhang; Chang Liu; Yawen Wang; Lin Zhang; Zhihong Shi; Zheng Wu; Yi Lv; Rongqian Wu
Journal:  JCI Insight       Date:  2020-07-09

7.  The A allele of the UCP2 -866G/A polymorphism changes UCP2 promoter activity in HUVECs treated with high glucose.

Authors:  Daisy Crispim; Michelle Rodrigues; Liana Paula Abreu da Silva; Ana Paula Bouças; Luís Henrique Canani; Rodrigo Carlessi; Bianca Marmontel de Souza
Journal:  Mol Biol Rep       Date:  2019-06-19       Impact factor: 2.316

Review 8.  Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases.

Authors:  Danielle L Kirkman; Austin T Robinson; Matthew J Rossman; Douglas R Seals; David G Edwards
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-09       Impact factor: 5.125

Review 9.  From Mitochondria to Atherosclerosis: The Inflammation Path.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; José A Sánchez-Alcázar
Journal:  Biomedicines       Date:  2021-03-05

Review 10.  The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies.

Authors:  Danina M Muntean; Adrian Sturza; Maria D Dănilă; Claudia Borza; Oana M Duicu; Cristian Mornoș
Journal:  Oxid Med Cell Longev       Date:  2016-04-21       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.